Asterias Biotherapeutics: 2Q Earnings Snapshot

August 9, 2018

FREMONT, Calif. (AP) _ Asterias Biotherapeutics Inc. (AST) on Thursday reported a loss of $7 million in its second quarter.

On a per-share basis, the Fremont, California-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring costs, were 10 cents per share.

The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.

The stem cell therapy developer posted revenue of $109,000 in the period.

In the final minutes of trading on Thursday, the company’s shares hit $1.58. A year ago, they were trading at $3.30.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AST at https://www.zacks.com/ap/AST

Update hourly